我院2012-2014年静脉用化疗药品用量分析

Analysis of the application of intravenous chemotherapy drugs in our hospital from 2012 to 2014

目的 :分析2012-2014年我院静脉用化疗药品用量,了解近年肿瘤患者用药的主要特点及药品的应用情况,为静脉用化疗药品应用和药物经济学研究提供参考。方法 :对上海同济大学附属同济医院2012-2014年静脉用化疗药品的销售金额和用药频度(DDDs)等进行统计并分析。结果 :大类中,我院静脉用抗肿瘤药品中抗代谢类药物的使用金额和DDDs最大。单药中,培美曲塞每年的使用金额最大,甲氨蝶呤每年的DDDs最大。结论 :我院静脉用抗肿瘤化疗药物的用量稳步上升,使用品种朝着高效、低毒、价廉发展。

Object： To analyze the intravenous medication for tumor chemotherapy during 2012-2014 and understand the main characters for the medication of patients with tumor and the application of drugs in recent years, so as to provide a reference for the clinical medication and the study of pharmacoeconomics. Methods： The sales and defined daily doses（DDDs） for intravenous tumor chemotherapy drugs were statistically analyzed. Results： The sales and DDDs of anti-metabolic drugs are the greatest in the categories. The annual sales for drug pemetrexed are the greatest in individual drug and the annual DDDs for methotrexate are the greatest. Conclusion： The amount of intravenous anti-tumor chemotherapy drugs in our hospital is steadily increasing and the varieties used show a trends of efficient, low toxicity and low cost development.